Global Corticosteroid Injections for Joint Pain Sales Market Report 2021

1 Corticosteroid Injections for Joint Pain Market Overview

• 1.1 Corticosteroid Injections for Joint Pain Product Scope
• 1.2 Corticosteroid Injections for Joint Pain Segment by Type
  • 1.2.1 Global Corticosteroid Injections for Joint Pain Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Knee & Ankle
  • 1.2.3 Hip Joint
  • 1.2.4 Shoulder & Elbow
  • 1.2.5 Facet Joints of the Spine
  • 1.2.6 Others
• 1.3 Corticosteroid Injections for Joint Pain Segment by Application
  • 1.3.1 Global Corticosteroid Injections for Joint Pain Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Hospital Pharmacies
  • 1.3.3 Retail Pharmacies
  • 1.3.4 Online Pharmacies
• 1.4 Corticosteroid Injections for Joint Pain Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Corticosteroid Injections for Joint Pain Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Corticosteroid Injections for Joint Pain Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Corticosteroid Injections for Joint Pain Price Trends (2016-2027)

2 Corticosteroid Injections for Joint Pain Estimates and Forecasts by Region

• 2.1 Global Corticosteroid Injections for Joint Pain Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Corticosteroid Injections for Joint Pain Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Corticosteroid Injections for Joint Pain Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Corticosteroid Injections for Joint Pain Revenue Market Share by Region (2016-2021)
• 2.3 Global Corticosteroid Injections for Joint Pain Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Corticosteroid Injections for Joint Pain Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Corticosteroid Injections for Joint Pain Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Corticosteroid Injections for Joint Pain Estimates and Projections (2016-2027)
  • 2.4.2 Europe Corticosteroid Injections for Joint Pain Estimates and Projections (2016-2027)
  • 2.4.3 China Corticosteroid Injections for Joint Pain Estimates and Projections (2016-2027)
  • 2.4.4 Japan Corticosteroid Injections for Joint Pain Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Corticosteroid Injections for Joint Pain Estimates and Projections (2016-2027)
  • 2.4.6 India Corticosteroid Injections for Joint Pain Estimates and Projections (2016-2027)

3 Global Corticosteroid Injections for Joint Pain Competition Landscape by Players

• 3.1 Global Top Corticosteroid Injections for Joint Pain Players by Sales (2016-2021)
• 3.2 Global Top Corticosteroid Injections for Joint Pain Players by Revenue (2016-2021)
• 3.3 Global Corticosteroid Injections for Joint Pain Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Corticosteroid Injections for Joint Pain as of 2020)
• 3.4 Global Corticosteroid Injections for Joint Pain Average Price by Company (2016-2021)
• 3.5 Manufacturers Corticosteroid Injections for Joint Pain Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Corticosteroid Injections for Joint Pain Market Size by Type

• 4.1 Global Corticosteroid Injections for Joint Pain Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Corticosteroid Injections for Joint Pain Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Corticosteroid Injections for Joint Pain Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Corticosteroid Injections for Joint Pain Price by Type (2016-2021)
• 4.2 Global Corticosteroid Injections for Joint Pain Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Corticosteroid Injections for Joint Pain Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Corticosteroid Injections for Joint Pain Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Corticosteroid Injections for Joint Pain Price Forecast by Type (2022-2027)

5 Global Corticosteroid Injections for Joint Pain Market Size by Application

• 5.1 Global Corticosteroid Injections for Joint Pain Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Corticosteroid Injections for Joint Pain Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Corticosteroid Injections for Joint Pain Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Corticosteroid Injections for Joint Pain Price by Application (2016-2021)
• 5.2 Global Corticosteroid Injections for Joint Pain Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Corticosteroid Injections for Joint Pain Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Corticosteroid Injections for Joint Pain Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Corticosteroid Injections for Joint Pain Price Forecast by Application (2022-2027)

6 North America Corticosteroid Injections for Joint Pain Market Facts & Figures

• 6.1 North America Corticosteroid Injections for Joint Pain Sales by Company
  • 6.1.1 North America Corticosteroid Injections for Joint Pain Sales by Company (2016-2021)
  • 6.1.2 North America Corticosteroid Injections for Joint Pain Revenue by Company (2016-2021)
• 6.2 North America Corticosteroid Injections for Joint Pain Sales Breakdown by Type
  • 6.2.1 North America Corticosteroid Injections for Joint Pain Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Corticosteroid Injections for Joint Pain Sales Breakdown by Type (2022-2027)
• 6.3 North America Corticosteroid Injections for Joint Pain Sales Breakdown by Application
  • 6.3.1 North America Corticosteroid Injections for Joint Pain Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Corticosteroid Injections for Joint Pain Sales Breakdown by Application (2022-2027)

7 Europe Corticosteroid Injections for Joint Pain Market Facts & Figures

• 7.1 Europe Corticosteroid Injections for Joint Pain Sales by Company
  • 7.1.1 Europe Corticosteroid Injections for Joint Pain Sales by Company (2016-2021)
  • 7.1.2 Europe Corticosteroid Injections for Joint Pain Revenue by Company (2016-2021)
• 7.2 Europe Corticosteroid Injections for Joint Pain Sales Breakdown by Type
  • 7.2.1 Europe Corticosteroid Injections for Joint Pain Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Corticosteroid Injections for Joint Pain Sales Breakdown by Type (2022-2027)
• 7.3 Europe Corticosteroid Injections for Joint Pain Sales Breakdown by Application
  • 7.3.1 Europe 136 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 136 Sales Breakdown by Application (2022-2027)

8 China Corticosteroid Injections for Joint Pain Market Facts & Figures

• 8.1 China Corticosteroid Injections for Joint Pain Sales by Company
  • 8.1.1 China Corticosteroid Injections for Joint Pain Sales by Company (2016-2021)
  • 8.1.2 China Corticosteroid Injections for Joint Pain Revenue by Company (2016-2021)
• 8.2 China Corticosteroid Injections for Joint Pain Sales Breakdown by Type
  • 8.2.1 China Corticosteroid Injections for Joint Pain Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Corticosteroid Injections for Joint Pain Sales Breakdown by Type (2022-2027)
• 8.3 China Corticosteroid Injections for Joint Pain Sales Breakdown by Application
  • 8.3.1 China 241 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 241 Sales Breakdown by Application (2022-2027)

9 Japan Corticosteroid Injections for Joint Pain Market Facts & Figures

• 9.1 Japan Corticosteroid Injections for Joint Pain Sales by Company
  • 9.1.1 Japan Corticosteroid Injections for Joint Pain Sales by Company (2016-2021)
  • 9.1.2 Japan Corticosteroid Injections for Joint Pain Revenue by Company (2016-2021)
• 9.2 Japan Corticosteroid Injections for Joint Pain Sales Breakdown by Type
  • 9.2.1 Japan Corticosteroid Injections for Joint Pain Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Corticosteroid Injections for Joint Pain Sales Breakdown by Type (2022-2027)
• 9.3 Japan Corticosteroid Injections for Joint Pain Sales Breakdown by Application
  • 9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Corticosteroid Injections for Joint Pain Market Facts & Figures

• 10.1 Southeast Asia Corticosteroid Injections for Joint Pain Sales by Company
  • 10.1.1 Southeast Asia Corticosteroid Injections for Joint Pain Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Corticosteroid Injections for Joint Pain Revenue by Company (2016-2021)
• 10.2 Southeast Asia Corticosteroid Injections for Joint Pain Sales Breakdown by Type
  • 10.2.1 Southeast Asia Corticosteroid Injections for Joint Pain Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Corticosteroid Injections for Joint Pain Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Corticosteroid Injections for Joint Pain Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Corticosteroid Injections for Joint Pain Market Facts & Figures

• 11.1 India Corticosteroid Injections for Joint Pain Sales by Company
  • 11.1.1 India Corticosteroid Injections for Joint Pain Sales by Company (2016-2021)
  • 11.1.2 India Corticosteroid Injections for Joint Pain Revenue by Company (2016-2021)
• 11.2 India Corticosteroid Injections for Joint Pain Sales Breakdown by Type
  • 11.2.1 India Corticosteroid Injections for Joint Pain Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Corticosteroid Injections for Joint Pain Sales Breakdown by Type (2022-2027)
• 11.3 India Corticosteroid Injections for Joint Pain Sales Breakdown by Application
  • 11.3.1 India Corticosteroid Injections for Joint Pain Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Corticosteroid Injections for Joint Pain Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Corticosteroid Injections for Joint Pain Business

• 12.1 Allergan
  • 12.1.1 Allergan Corporation Information
  • 12.1.2 Allergan Business Overview
  • 12.1.3 Allergan Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Allergan Corticosteroid Injections for Joint Pain Products Offered
  • 12.1.5 Allergan Recent Development
• 12.2 Pfizer
  • 12.2.1 Pfizer Corporation Information
  • 12.2.2 Pfizer Business Overview
  • 12.2.3 Pfizer Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Pfizer Corticosteroid Injections for Joint Pain Products Offered
  • 12.2.5 Pfizer Recent Development
• 12.3 Sanofi
  • 12.3.1 Sanofi Corporation Information
  • 12.3.2 Sanofi Business Overview
  • 12.3.3 Sanofi Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Sanofi Corticosteroid Injections for Joint Pain Products Offered
  • 12.3.5 Sanofi Recent Development
• 12.4 Anika Therapeutics
  • 12.4.1 Anika Therapeutics Corporation Information
  • 12.4.2 Anika Therapeutics Business Overview
  • 12.4.3 Anika Therapeutics Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Anika Therapeutics Corticosteroid Injections for Joint Pain Products Offered
  • 12.4.5 Anika Therapeutics Recent Development
• 12.5 Ferring
  • 12.5.1 Ferring Corporation Information
  • 12.5.2 Ferring Business Overview
  • 12.5.3 Ferring Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Ferring Corticosteroid Injections for Joint Pain Products Offered
  • 12.5.5 Ferring Recent Development
• 12.6 Bioventus
  • 12.6.1 Bioventus Corporation Information
  • 12.6.2 Bioventus Business Overview
  • 12.6.3 Bioventus Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Bioventus Corticosteroid Injections for Joint Pain Products Offered
  • 12.6.5 Bioventus Recent Development
• 12.7 Flexion Therapeutics
  • 12.7.1 Flexion Therapeutics Corporation Information
  • 12.7.2 Flexion Therapeutics Business Overview
  • 12.7.3 Flexion Therapeutics Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Flexion Therapeutics Corticosteroid Injections for Joint Pain Products Offered
  • 12.7.5 Flexion Therapeutics Recent Development
• 12.8 Zimmer Biomet
  • 12.8.1 Zimmer Biomet Corporation Information
  • 12.8.2 Zimmer Biomet Business Overview
  • 12.8.3 Zimmer Biomet Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Zimmer Biomet Corticosteroid Injections for Joint Pain Products Offered
  • 12.8.5 Zimmer Biomet Recent Development
• 12.9 SEIKAGAKU
  • 12.9.1 SEIKAGAKU Corporation Information
  • 12.9.2 SEIKAGAKU Business Overview
  • 12.9.3 SEIKAGAKU Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 SEIKAGAKU Corticosteroid Injections for Joint Pain Products Offered
  • 12.9.5 SEIKAGAKU Recent Development
• 12.10 Chugai Pharma
  • 12.10.1 Chugai Pharma Corporation Information
  • 12.10.2 Chugai Pharma Business Overview
  • 12.10.3 Chugai Pharma Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Chugai Pharma Corticosteroid Injections for Joint Pain Products Offered
  • 12.10.5 Chugai Pharma Recent Development

13 Corticosteroid Injections for Joint Pain Manufacturing Cost Analysis

• 13.1 Corticosteroid Injections for Joint Pain Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Corticosteroid Injections for Joint Pain
• 13.4 Corticosteroid Injections for Joint Pain Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Corticosteroid Injections for Joint Pain Distributors List
• 14.3 Corticosteroid Injections for Joint Pain Customers

15 Market Dynamics

• 15.1 Corticosteroid Injections for Joint Pain Market Trends
• 15.2 Corticosteroid Injections for Joint Pain Drivers
• 15.3 Corticosteroid Injections for Joint Pain Market Challenges
• 15.4 Corticosteroid Injections for Joint Pain Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List